HOBOKEN, N.J., June 28, 2016 /PRNewswire/ -- The recent U.S. availability of natural French wood extract Robuvit® is notable news for millions who suffer from general and chronic fatigue, say a leading natural health physician and an expert ingredient scientist.
Two recently published studies show Robuvit® is effective in alleviating nagging symptoms associated with fatigue such as aching joints, headaches and sore throat and improving energy, vitality and mood.
"Fatigue is a condition that impacts and mystifies millions of Americans; it's not just feeling sleep-deprived or excessive yawning – it's frustrating because even attempts at the recommended seven to eight hours of sleep do not seem to help," said renowned natural health expert and best-selling author Dr. Fred Pescatore.
"The participants in these studies who supplemented with Robuvit® reported significant improvement in the nagging symptoms that come with fatigue," continued Dr. Pescatore, "They felt better, they felt more energy and they felt less irritable due to fatigue."
Nearly 25 percent of American adults suffer from fatigue
According to the National Library of Medicine, fatigue affects 25 percent1 of adults in the U.S. and can produce troublesome symptoms like lack of energy, always feeling tired, and lapses in memory and concentration.
A 2015 study of healthy individuals published in Phytotherapy Research showed that general fatigue-sufferers who supplemented daily with Robuvit® reported feeling more energy and fewer symptoms in as little as four weeks. The study, aimed at examining the psychological benefits of taking Robuvit®, varied dosages of the supplement to test efficacy in subjects between 45 and 65-years-old.
The results? "Those who supplemented daily with Robuvit® reported an improvement in their overall mood and mental state. The group that took Robuvit® was less tired, less tense and said they felt more energetic as well as a greater sense of calmness," said Director of Scientific Communications Dr. Frank Schoenlau of Horphag Research, the distributor of the ingredient.
"The physical impact of fatigue takes a toll on mood and mental state and this study demonstrates the effectiveness of Robuvit® in those areas," Dr. Schoenlau added.
More than one million suffer from Chronic Fatigue Syndrome
A 2013 peer-reviewed study published in Panminerva Medica examined the effects of Robuvit® on participants with Chronic Fatigue Syndrome (CFS) symptoms and found sufferers reported improvement in nagging symptoms such as joint discomfort, loss of memory and concentration, poor sleep quality, headaches, sore throat and extreme exhaustion.
"After six months of taking 200 mg of Robuvit® daily, chronic fatigue sufferers said they felt better overall with some even noting a marked improvement after just three months," said Dr. Schoenlau.
"The study revealed that Robuvit® supplementation reduced levels of oxidative stress," added Dr. Schoenlau. "Increased levels of oxidative stress are one of the major precursors of chronic fatigue. This pilot study showed Robuvit® was effective in targeting the root cause of the condition."
According to the U.S. Centers for Disease Control, more than one million Americans suffer from CFS. The condition occurs most often in those in their 40's and 50's but can affect anyone at any age and affects their quality of life for months on end.
"I'm especially intrigued by what the research on Robuvit® indicates for those managing chronic fatigue, which is a devastating and complex disorder," said Dr. Pescatore. "More importantly, the supplement carried no side effects which, is an important factor for patients to consider when considering options to help them manage their chronic fatigue symptoms."
A Natural, Safe and Effective Option
Robuvit® is a patented natural extract from French oak wood, rich in roburins and other flavonoids unique to oak wood.
Oak has been considered the most venerated tree for centuries with its wood prized for its resilience, flavor and preservative effects, which is why it is used to store and age wines and spirits. Scientists have discovered that roburins – a unique class of tannins found only within select oak trees – provide many of these coveted attributes. Research shows that roburins enhance basic cellular functions to combat the aging process, increase energy and fend off fatigue.
Research has identified enhanced replacement of aged and malfunctioned enzymes and neuronal proteins as foundation for the experienced greater mental alertness and fitness. Body cells have compartments (ribosomes) which replenish neuronal building blocks and other relevant proteins, resulting in better functional proteins, enzymes and neuronal modulators.
"We applied decades of expertise to develop Robuvit® as a standardized, GMO-free extract rich in roburins and other French oak flavonoids, with an impressive polyphenol content," Dr. Schoenlau said of the brand.
"Individuals dealing with fatigue have long thought that there was no hope for treating their symptoms which can have a daily effect," said Dr. Pescatore. "This Robuvit® research raises a potential solution. For many, there's a big relief in just knowing that they can indeed feel better."
Products containing Robuvit® can be found on www.Robuvit.com
About Horphag Research (USA) Inc.
Horphag Research (USA) Inc., based in Hoboken, New Jersey, is the North American distributor for Pycnogenol® (pic-noj-en-all) brand French maritime pine bark extract and Robuvit®, French oak wood extract on behalf of Horphag Research. Pycnogenol® and Robuvit® are registered trademarks of Horphag Research Ltd. For its patented ingredient, Pycnogenol®, Horphag Research has been awarded the Frost & Sullivan Excellence in Research Award, Nutraceutical Business & Technology Safety & Quality Award, SupplySide West Scientific Excellence Award and The American Botanical Council's Tyler Research Award. Horphag Research (USA) has the exclusive rights to market and sell Pycnogenol® and Robuvit® in North America. For more information, visit www.pycnogenol.com and www.robuvit.com.
1 Prevalence of fatigue in general practice, National Center for Biotechnology Information, U.S. National Library of Medicine
Access link: http://www.ncbi.nlm.nih.gov/pubmed/11993585
SOURCE Horphag Research (USA) Inc.